These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19820025)

  • 1. Predicting recurrence of nonfunctioning pituitary adenomas.
    Noh TW; Jeong HJ; Lee MK; Kim TS; Kim SH; Lee EJ
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4406-13. PubMed ID: 19820025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
    Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
    World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
    Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence.
    Losa M; Mortini P; Barzaghi R; Ribotto P; Terreni MR; Marzoli SB; Pieralli S; Giovanelli M
    J Neurosurg; 2008 Mar; 108(3):525-32. PubMed ID: 18312100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
    Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
    Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma.
    Gopalan R; Schlesinger D; Vance ML; Laws E; Sheehan J
    Neurosurgery; 2011 Aug; 69(2):284-93. PubMed ID: 21792138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results.
    Losa M; Franzin A; Mangili F; Terreni MR; Barzaghi R; Veglia F; Mortini P; Giovanelli M
    Neurosurgery; 2000 Dec; 47(6):1313-8; discussion 1318-9. PubMed ID: 11126902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
    Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
    Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The usefulness of adjuvant therapy using gamma knife radiosurgery for the recurrent or residual nonfunctioning pituitary adenomas].
    Iwai Y; Yamanaka K; Yoshioka K; Yoshimura M; Honda Y; Matsusaka Y; Komiyama M; Yasui T
    No Shinkei Geka; 2005 Aug; 33(8):777-83. PubMed ID: 16095207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
    Miyagami M; Nakamura S
    No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.
    Zhu H; Yao X; Wu L; Li C; Bai J; Gao H; Ji H; Zhang Y
    World Neurosurg; 2018 Nov; 119():e23-e31. PubMed ID: 29966778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma.
    Dekkers OM; Pereira AM; Roelfsema F; Voormolen JH; Neelis KJ; Schroijen MA; Smit JW; Romijn JA
    J Clin Endocrinol Metab; 2006 May; 91(5):1796-801. PubMed ID: 16507632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth.
    Šteňo A; Bocko J; Rychlý B; Chorváth M; Celec P; Fabian M; Belan V; Šteňo J
    Acta Neurochir (Wien); 2014 Mar; 156(3):451-61; discussion 461. PubMed ID: 24452592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas.
    Gejman R; Swearingen B; Hedley-Whyte ET
    Hum Pathol; 2008 May; 39(5):758-66. PubMed ID: 18439942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study.
    Ramírez C; Cheng S; Vargas G; Asa SL; Ezzat S; González B; Cabrera L; Guinto G; Mercado M
    J Clin Endocrinol Metab; 2012 May; 97(5):1745-51. PubMed ID: 22419713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients.
    Brochier S; Galland F; Kujas M; Parker F; Gaillard S; Raftopoulos C; Young J; Alexopoulou O; Maiter D; Chanson P
    Eur J Endocrinol; 2010 Aug; 163(2):193-200. PubMed ID: 20460423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas.
    Dekkers OM; Pereira AM; Romijn JA
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3717-26. PubMed ID: 18682516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery.
    Dubois S; Guyétant S; Menei P; Rodien P; Illouz F; Vielle B; Rohmer V
    Eur J Endocrinol; 2007 Aug; 157(2):141-7. PubMed ID: 17656591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.